US Patent Issued to Celgene, Zoetis on June 24 for "Heterocyclic compounds and their use for treatment of helminthic infections and diseases" (California, Colorado, Michigan Inventors)

ALEXANDRIA, Va., June 25 -- United States Patent no. 12,338,235, issued on June 24, was assigned to Celgene Corp. (Summit, N.J.) and Zoetis LLC (Kalamazoo, Mich.).

"Heterocyclic compounds and their use for treatment of helminthic infections and diseases" was invented by Natalie Hawryluk (San Diego), Stacie S. Canan (La Jolla, Calif.), Kevin R. Condroski (Lafayette, Colo.), Graham Kyne (Kalamazoo, Mich.), Matthew Bedore (Portage, Mich.) and Sanjay Menon (Kalamazoo, Mich.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are Heterocyclic compounds of formula I: and pharmaceutically acceptable salts, tautomers, isotopologues, or stereoisomers thereof, wherein W, X, Y, R1, R2, and RN are as defined ...